Clinical trial

Ranolazine in Diastolic Heart Failure

NCT01163734

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE2

Study timeline

Study start (unknown)2010-04-01Date precision: month

Registry last updated2012-07-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diastolic Heart Failureverified · MONDO: diastolic heart failure

Interventions

RanolazineDRUG · verified · RxNorm: ranolazine

Saline 0.9% and placebo tabletOTHER

Sponsors & collaborators

Gilead Scienceslead sponsor

University Medicine Göttingen, Cardiac Centercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01163734 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.